Geode Capital Management, LLC Atara Biotherapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,158,591 shares of ATRA stock, worth $16.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,158,591

Previous 2,150,150 0.39%

Holding current value

$16.6 Million

Previous $1.1 Million 35.86%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.44 - $1.22 $3,714 - $10,298	8,441 Added 0.39%	2,158,591 $1.49 Million
Q4 2023 Feb 13, 2024	BUY	$0.23 - $1.74 $16,922 - $128,020	73,575 Added 3.54%	2,150,150 $1.1 Million
Q3 2023 Nov 13, 2023	BUY	$1.41 - $2.31 $63,481 - $104,000	45,022 Added 2.22%	2,076,575 $3.07 Million
Q2 2023 Aug 11, 2023	BUY	$1.5 - $3.04 $175,462 - $355,604	116,975 Added 6.11%	2,031,553 $3.27 Million
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $198,688 - $387,441	70,960 Added 3.85%	1,914,578 $5.55 Million

Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $206,037 - $374,482	72,294 Added 4.08%	1,843,618 $6.05 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $170,640 - $522,700	59,874 Added 3.5%	1,771,324 $6.7 Million
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $142,313 - $298,584	30,344 Added 1.81%	1,711,450 $13.3 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $511,810 - $1.02 Million	60,641 Added 3.74%	1,681,106 $15.6 Million
Q4 2021 Feb 11, 2022	BUY	$14.7 - $19.89 $2.17 Million - $2.94 Million	147,643 Added 10.02%	1,620,465 $25.5 Million
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $497,608 - $742,885	-41,502 Reduced 2.74%	1,472,822 $26.4 Million
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $1.22 Million - $1.57 Million	94,888 Added 6.68%	1,514,324 $23.5 Million
Q1 2021 May 12, 2021	BUY	$14.0 - $20.72 $3.01 Million - $4.45 Million	214,895 Added 17.84%	1,419,436 $20.4 Million
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $1.79 Million - $3.7 Million	141,106 Added 13.27%	1,204,541 $23.6 Million
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $2.13 Million - $2.84 Million	178,761 Added 20.21%	1,063,435 $13.8 Million
Q2 2020 Aug 13, 2020	BUY	$7.53 - $14.93 $428,788 - $850,173	56,944 Added 6.88%	884,674 $12.9 Million
Q1 2020 May 14, 2020	BUY	$5.69 - $17.78 $536,470 - $1.68 Million	94,283 Added 12.85%	827,730 $7.04 Million
Q4 2019 Feb 13, 2020	BUY	$10.89 - $16.79 $402,439 - $620,474	36,955 Added 5.31%	733,447 $12.1 Million
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $1.2 Million - $1.98 Million	99,509 Added 16.67%	696,492 $9.83 Million
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $972,921 - $2.1 Million	51,072 Added 9.36%	596,983 $12 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $41.74 $1.36 Million - $2 Million	47,833 Added 9.6%	545,911 $21.7 Million
Q4 2018 Feb 13, 2019	BUY	$30.9 - $42.97 $1.44 Million - $2 Million	46,546 Added 10.31%	498,078 $17.3 Million
Q3 2018 Nov 13, 2018	BUY	$35.05 - $43.5 $906,112 - $1.12 Million	25,852 Added 6.07%	451,532 $18.7 Million
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $2.6 Million - $3.8 Million	73,927 Added 21.02%	425,680 $15.6 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $2.79 Million - $7.49 Million	154,912 Added 78.7%	351,753 $13.7 Million
Q4 2017 Feb 13, 2018	BUY	$13.2 - $18.1 $62,449 - $85,631	4,731 Added 2.46%	196,841 $3.56 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $48,826 - $62,829	3,685 Added 1.96%	192,110 $3.18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	188,425	188,425 $2.64 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Atara Biotherapeutics, Inc. Transaction History